Index -
P/E -
EPS (ttm) -0.55
Insider Own 63.08%
Shs Outstand 96.24M
Perf Week 20.30%
Market Cap 183.50M
Forward P/E -
EPS next Y -0.26
Insider Trans -0.16%
Shs Float 42.35M
Perf Month 4.92%
Income -47.06M
PEG -
EPS next Q -0.09
Inst Own 17.57%
Short Float 0.54%
Perf Quarter 8.84%
Sales 54.85M
P/S 3.35
EPS this Y 43.06%
Inst Trans 15.77%
Short Ratio 1.56
Perf Half Y 1.27%
Book/sh -0.06
P/B -
EPS next Y 27.37%
ROA -56.02%
Short Interest 0.23M
Perf Year 9.59%
Cash/sh 0.10
P/C 15.83
EPS next 5Y -
ROE -414.09%
52W Range 1.03 - 2.21
Perf YTD -13.04%
Dividend Est. -
P/FCF -
EPS past 5Y 8.42%
ROI -85.01%
52W High -27.60%
Beta 1.21
Dividend TTM -
Quick Ratio 0.87
Sales past 5Y 24.79%
Gross Margin 76.27%
52W Low 55.34%
ATR (14) 0.11
Dividend Ex-Date -
Current Ratio 0.91
EPS Y/Y TTM 59.03%
Oper. Margin -65.45%
RSI (14) 62.57
Volatility 7.58% 7.17%
Employees 217
Debt/Eq -
Sales Y/Y TTM 34.69%
Profit Margin -85.80%
Recom 1.00
Target Price 3.10
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 41.75%
Payout -
Rel Volume 2.03
Prev Close 1.58
Sales Surprise 4.49%
EPS Surprise 1.48%
Sales Q/Q 63.63%
Earnings May 08 AMC
Avg Volume 145.50K
Price 1.60
SMA20 10.44%
SMA50 15.09%
SMA200 2.89%
Trades
Volume 294,913
Change 1.27%
Date
Action
Analyst
Rating Change
Price Target Change
May-13-24 Initiated
TD Cowen
Buy
$2.80
May-03-24 Initiated
Lake Street
Buy
$3
Nov-17-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$21 → $11
Nov-23-20 Initiated
William Blair
Outperform
Nov-23-20 Initiated
Morgan Stanley
Overweight
$20
Nov-23-20 Initiated
Canaccord Genuity
Buy
$26
Nov-23-20 Initiated
BTIG Research
Buy
$22
May-28-24 06:00AM
May-21-24 06:00AM
May-10-24 05:59PM
03:55PM
May-09-24 03:46AM
09:00PM
Loading…
May-08-24 09:00PM
05:20PM
04:01PM
May-07-24 06:00AM
Apr-24-24 06:00AM
Apr-09-24 05:00PM
Apr-05-24 07:17AM
Mar-25-24 06:00AM
Mar-04-24 09:04AM
Mar-01-24 10:40PM
(Thomson Reuters StreetEvents)
06:31AM
Loading…
06:31AM
06:00AM
Feb-26-24 06:00AM
Feb-16-24 06:00AM
Feb-13-24 03:00AM
Jan-26-24 09:04AM
Nov-14-23 06:00AM
Nov-09-23 06:00AM
Nov-07-23 04:01PM
Oct-24-23 06:00AM
Oct-03-23 06:00AM
Sep-07-23 06:00AM
Sep-05-23 06:00AM
Aug-22-23 06:00AM
Aug-09-23 10:25AM
08:38AM
Loading…
Aug-08-23 08:38AM
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
04:01PM
Aug-01-23 06:00AM
Jul-26-23 07:58AM
Jul-24-23 06:00AM
Jul-12-23 06:00AM
Jul-06-23 09:11AM
Jun-27-23 06:00AM
Jun-01-23 06:00AM
May-31-23 06:00AM
May-28-23 08:09AM
May-25-23 06:00AM
May-24-23 06:00AM
May-18-23 07:00AM
May-12-23 11:10AM
(Thomson Reuters StreetEvents) -12.28%
May-11-23 05:25PM
04:01PM
May-09-23 06:15PM
Apr-27-23 06:00AM
Apr-12-23 06:53AM
Mar-15-23 09:31AM
(Simply Wall St.) +15.24%
Mar-08-23 07:14AM
Mar-06-23 07:25AM
06:00AM
Feb-28-23 06:00AM
Feb-21-23 06:00AM
Feb-16-23 06:27AM
Dec-19-22 06:00AM
Dec-16-22 04:01PM
Dec-12-22 06:00AM
Nov-21-22 04:01PM
Nov-17-22 12:26AM
Nov-16-22 04:05PM
04:01PM
Nov-10-22 09:00AM
Nov-09-22 05:33AM
Nov-03-22 07:15AM
06:00AM
Oct-20-22 06:00AM
Oct-17-22 05:05PM
(American City Business Journals)
06:00AM
Oct-12-22 06:00AM
Oct-11-22 06:00AM
Sep-06-22 06:00AM
Aug-09-22 06:00AM
Aug-06-22 04:30AM
Aug-04-22 07:15AM
06:00AM
Aug-03-22 06:00AM
Jul-30-22 10:44AM
Jul-20-22 06:00AM
Jul-19-22 06:00AM
Jun-22-22 09:19AM
Jun-15-22 10:11AM
Jun-07-22 06:00AM
Jun-03-22 06:00AM
Jun-01-22 06:00AM
May-17-22 06:00AM
May-12-22 06:00AM
May-11-22 07:15AM
06:00AM
Apr-27-22 06:00AM
Apr-12-22 08:58AM
Apr-11-22 06:00AM
Mar-29-22 06:00AM
Mar-19-22 09:19AM
Mar-15-22 10:00AM
Mar-14-22 07:15AM
06:00AM
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Boulder, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cowie Robin Harper CFO, Sec'y & Treasurer May 21 '24 Option Exercise 0.42 4,209 1,768 175,889 May 23 07:13 PM Hutton Scott President & CEO May 09 '24 Sale 1.48 3,764 5,569 483,780 May 10 05:04 PM Cowie Robin Harper CFO, Sec'y & Treasurer May 09 '24 Sale 1.48 980 1,450 171,680 May 10 05:04 PM O'Kane Kieran Chief Commercial Officer May 09 '24 Sale 1.48 468 692 75,524 May 10 05:05 PM Pestano Gary Anthony Chief Development Officer May 09 '24 Sale 1.48 434 642 124,248 May 10 05:06 PM Vazquez Chris Chief Accounting Officer May 09 '24 Sale 1.48 244 361 9,915 May 10 05:06 PM Hutton Scott President & CEO Feb 12 '24 Sale 1.66 29,708 49,455 465,011 Feb 12 09:45 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 12 '24 Sale 1.66 8,699 14,481 169,410 Feb 12 09:44 PM O'Kane Kieran Chief Commercial Officer Feb 12 '24 Sale 1.66 5,412 9,009 68,005 Feb 12 09:45 PM Pestano Gary Anthony Chief Development Officer Feb 12 '24 Sale 1.66 5,022 8,360 123,250 Feb 12 09:45 PM Vazquez Chris Chief Accounting Officer Feb 12 '24 Sale 1.66 922 1,535 9,548 Feb 12 09:46 PM Hutton Scott President & CEO Feb 09 '24 Sale 1.92 34,682 66,472 494,719 Feb 12 09:45 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 09 '24 Sale 1.92 10,156 19,465 178,109 Feb 12 09:44 PM O'Kane Kieran Chief Commercial Officer Feb 09 '24 Sale 1.92 6,319 12,111 73,417 Feb 12 09:45 PM Pestano Gary Anthony Chief Development Officer Feb 09 '24 Sale 1.92 5,862 11,235 128,272 Feb 12 09:45 PM Vazquez Chris Chief Accounting Officer Feb 09 '24 Sale 1.92 1,077 2,064 10,470 Feb 12 09:46 PM Hutton Scott President & CEO Nov 10 '23 Sale 1.23 1,883 2,308 329,428 Nov 13 04:50 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 10 '23 Sale 1.23 491 602 136,573 Nov 13 04:50 PM O'Kane Kieran Chief Commercial Officer Nov 10 '23 Sale 1.23 235 288 47,712 Nov 13 04:50 PM Pestano Gary Anthony Chief Development Officer Nov 10 '23 Sale 1.23 218 267 104,501 Nov 13 04:51 PM Vazquez Chris Chief Accounting Officer Nov 10 '23 Sale 1.23 108 132 6,251 Nov 13 04:51 PM Hutton Scott President & CEO Nov 09 '23 Sale 1.27 1,882 2,391 331,311 Nov 13 04:50 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 09 '23 Sale 1.27 491 624 137,064 Nov 13 04:50 PM O'Kane Kieran Chief Commercial Officer Nov 09 '23 Sale 1.27 234 297 47,947 Nov 13 04:50 PM Pestano Gary Anthony Chief Development Officer Nov 09 '23 Sale 1.27 217 276 104,719 Nov 13 04:51 PM Vazquez Chris Chief Accounting Officer Nov 09 '23 Sale 1.27 107 136 6,359 Nov 13 04:51 PM SCHULER JACK W Director Aug 23 '23 Buy 1.71 87,500 149,240 30,707,722 Aug 23 06:56 PM SCHULER JACK W Director Aug 22 '23 Buy 1.67 8,307 13,859 30,620,222 Aug 23 06:56 PM SCHULER JACK W Director Aug 21 '23 Buy 1.64 32,556 53,411 30,611,915 Aug 23 06:56 PM Hutton Scott President & CEO Aug 10 '23 Sale 1.27 6,889 8,728 318,013 Aug 10 07:28 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 10 '23 Sale 1.27 1,788 2,265 131,535 Aug 10 07:27 PM O'Kane Kieran Chief Commercial Officer Aug 10 '23 Sale 1.27 849 1,076 46,692 Aug 10 07:28 PM Pestano Gary Anthony Chief Development Officer Aug 10 '23 Sale 1.27 786 996 103,558 Aug 10 07:29 PM Vazquez Chris Chief Accounting Officer Aug 10 '23 Sale 1.27 279 353 5,865 Aug 10 07:30 PM Hutton Scott President & CEO Aug 09 '23 Sale 1.39 6,893 9,570 324,902 Aug 10 07:28 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 09 '23 Sale 1.39 1,789 2,484 133,323 Aug 10 07:27 PM O'Kane Kieran Chief Commercial Officer Aug 09 '23 Sale 1.39 850 1,180 47,541 Aug 10 07:28 PM Pestano Gary Anthony Chief Development Officer Aug 09 '23 Sale 1.39 787 1,093 104,344 Aug 10 07:29 PM Vazquez Chris Chief Accounting Officer Aug 09 '23 Sale 1.39 280 389 6,144 Aug 10 07:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite